On Friday, November 20, a forum dedicated to opportunities for accessing medical care in Uzbekistan will be held at the Hyatt Regency Tashkent hotel. According to organizers quoted by Gazeta, the event is being organized by the European-Uzbek Economic Cooperation Association (EUROUZ) and pharmaceutical company AstraZeneca. Participants will discuss how to shorten the patient pathway from the first symptoms to diagnosis and the start of treatment. The forum is open to all interested parties, although prior registration is required; online participation is also available, and both formats are free.
Key Takeaways: The free forum in Tashkent on November 20 will address state medical insurance, oncology, rare and hereditary childhood diseases, and the registration and quality control of medicines; participation is available online or in person after registration; and financing for oncology care is scheduled to be reviewed separately from 2027.
Improving access to timely diagnosis and treatment remains a key priority for Uzbekistan's healthcare system, particularly as it seeks to connect insurance funds, medical institutions, pharmacies, specialized centers and patient organizations. By bringing together four discussion sessions, the forum aims to identify practical ways to reduce delays between first symptoms and therapy, clarify funding mechanisms and strengthen quality assurance across the medical supply chain.
The first session will examine the introduction of state medical insurance, the sources used to finance medical care and medicines, criteria for adding drugs to reimbursed lists, and the organization of outpatient drug provision, including cooperation among insurance funds, healthcare facilities and pharmacies. The oncology session will focus on early cancer detection, wider use of molecular-genetic diagnostics, and the use of oncology registry data to assess therapy outcomes and plan drug procurement; financing for oncology care from 2027 will also be reviewed. Experts from oncology and hematology centers, including Abdurahmon Qayumov, chief physician of the Hematology Center, have been invited.
The session on support for children with rare and hereditary diseases will address early detection, referral for genetic testing, the organization of specialized centers, and state payment and procurement of expensive medicines for small patient groups. Representatives of the Ministry of Health, specialized medical centers and patient organizations are expected to attend. The final session will cover registration and quality control of medicines and medical devices, including e-prescriptions, the languages of electronic instructions and their harmonization with paper versions, import procedures for unregistered drugs and medicines without alternatives, and quality testing of pharmaceuticals.
Organizers expect the discussions to provide practical recommendations for improving access to medical care. Those interested can register and follow the November 20 forum online or in person, while the next stage will depend on regulators, healthcare providers, the insurance fund and pharmaceutical market participants turning the discussed proposals into practice.
Source: www.gazeta.uz